Patents by Inventor Phillip D. Foshee, Jr.

Phillip D. Foshee, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220225949
    Abstract: In one embodiment, a method to track cardiac health of a patient is described. The method includes communicating, via a mobile device, to a cardiac device worn by the patient, wherein the cardiac device includes at least one sensor. The method also includes receiving cardiac device data from the cardiac device and filtering the cardiac device data based at least in part on patient logic rules. The method includes pushing the cardiac device data to one or more personnel based at least in part on the patient logic rules.
    Type: Application
    Filed: November 3, 2021
    Publication date: July 21, 2022
    Applicant: West Affum Holdings Corp.
    Inventors: Traci S. Umberger, Brian D. Webster, Phillip D. Foshee, JR., Gordon P. Teddy, Krystyna Szul
  • Patent number: 11364388
    Abstract: A wearable cardioverter defibrillator (WCD) comprises a support structure to be worn by a patient, an energy storage module to store an electrical charge, a discharge circuit coupled to the energy storage module, a measurement circuit, a user interface that includes a speaker, and a processor. The processor is configured to monitor a physiological signal of a patient with the measurement circuit to detect cardiac arrhythmia when the patient is wearing the support structure, determine whether a validation criterion is met in response to detection of a cardiac arrhythmia, provide no alarm with the user interface the validation criterion is being determined, and cause a shock to be delivered to the patient from the energy storage module by the discharge circuit in the event the validation criterion is met.
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: June 21, 2022
    Assignee: West Affum Holdings Corp.
    Inventors: Phillip D. Foshee, Jr., David P. Finch, Laura M. Gustavson, Nikolai Korsun, Joseph L. Sullivan, Gregory T. Kavounas
  • Patent number: 11278731
    Abstract: In some embodiments, a wearable cardioverter defibrillator (“WCD”) system comprises a support structure configured to be worn by a patient, a power source, an energy storage module configured to be coupled to the support structure, to be charged from the power source and to store an electrical charge, a discharge circuit coupled to the energy storage module, the discharge circuit controllable to discharge the electrical charge so as to cause a shock to be delivered to the patient, a measurement circuit configured to render a physiological input from a patient physiological signal, a user interface configured to output one or more human-perceptible indications, and a processor.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: March 22, 2022
    Assignee: West Affum Holdings Corp.
    Inventors: Phillip D. Foshee, Jr., David P. Finch, Laura M. Gustavson, Nikolai Korsun, Joseph L. Sullivan, Gregory T. Kavounas
  • Publication number: 20220022767
    Abstract: A Wearable Cardioverter Defibrillator (WCD) system comprises an electrode assembly with a permeable ECG electrode and a moisture barrier. In some embodiments, the moisture barrier is configured to reduce drying out of the permeable ECG electrode to improve performance of the WCD system. In a further enhancement, some embodiments of the electrode assembly also include a pillow structure positioned on a non-skin-contacting surface of the electrode assembly to comfortably reduce movement artifact or noise in the received ECG signal.
    Type: Application
    Filed: November 20, 2018
    Publication date: January 27, 2022
    Inventors: Dallas E. Meeker, Kiah Lesher, Douglas K. Medema, Robert R. Buchanan, Zoie R. Engman, Phillip D. Foshee, JR., David P. Finch
  • Publication number: 20210361961
    Abstract: A wearable cardioverter defibrillator (WCD) having a processor configured to receive a signal indicating a position and/or movement of the ambulatory patient while the ambulatory patient is wearing the support structure receive the ECG signal, determine from an ECG signal whether a shock criterion is met, determine a confirmation time period and/or a response time period based on the position and/or movement of the ambulatory patient, determine from the ECG signal whether the shock criterion is met after the confirmation time period has elapsed, cause the user interface to generate the shock alert signal based on the shock criterion determined after the confirmation time period has elapsed, and control the discharge circuit to discharge the stored electrical charge when a predetermined time period has elapsed after the shock alert signal.
    Type: Application
    Filed: August 4, 2021
    Publication date: November 25, 2021
    Applicant: West Affum Holdings Corp.
    Inventors: Phillip D. Foshee, JR., David P. Finch, Pamela Breske, Laura M. Gustavson, Joseph L. Sullivan, Jaeho Kim
  • Publication number: 20210339031
    Abstract: In embodiments, a Wearable Cardioverter Defibrillator (WCD) system includes a support structure for the patient to wear, and components that the support structure maintains on the patient's body. The components include a defibrillator, associated electrodes, and so on. The defibrillator can operate in a WCD mode while the patient wears the support structure. The defibrillator can further operate in a different, AED mode, during which time the patient need not wear a portion of the support structure, or even the entire support structure. Sometimes the AED mode is a type of a fully automatic AED mode. Other times the AED mode is a type of a semi-automated AED mode, where an attendant is present to administer the shock; at such times, the patient may not even need to have electrodes attached. This way the patient is more comfortable for a longer time.
    Type: Application
    Filed: July 16, 2021
    Publication date: November 4, 2021
    Applicant: West Affum Holdings Corp.
    Inventors: Brian D. Webster, Zoie R. Engman, Phillip D. Foshee, JR., David P. Finch, Joseph L. Sullivan, Gregory T. Kavounas
  • Patent number: 11065463
    Abstract: In embodiments, a Wearable Cardioverter Defibrillator (WCD) system includes a support structure for the patient to wear, and components that the support structure maintains on the patient's body. The components include a defibrillator, associated electrodes, and so on. The defibrillator can operate in a WCD mode while the patient wears the support structure. The defibrillator can further operate in a different, AED mode, during which time the patient need not wear a portion of the support structure, or even the entire support structure. Sometimes the AED mode is a type of a fully automatic AED mode. Other times the AED mode is a type of a semi-automated AED mode, where an attendant is present to administer the shock; at such times, the patient may not even need to have electrodes attached. This way the patient is more comfortable for a longer time.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: July 20, 2021
    Assignee: West Affum Holdings Corp.
    Inventors: Brian D. Webster, Zoie Engman, Phillip D. Foshee, Jr., David P. Finch, Joseph L. Sullivan, Gregory T. Kavounas
  • Publication number: 20210022621
    Abstract: A sensor substrate to detect heart failure decompensation comprises a substrate structure, wherein the substrate structure is configured to have a patient sit, recline, or lie on a surface of the substrate structure, one or more sensors in the substrate structure, wherein the one or more sensors are configured to detect a plurality of parameters of the patient when the patient is in contact with the substrate structure, an interface in the substrate structure to receive an output from the one or more sensors, and a processor, wherein the processor is configured to detect heart failure decompensation in the patient from the plurality of parameters detected by the one or more sensors when the patient is in contact with the substrate structure.
    Type: Application
    Filed: July 27, 2020
    Publication date: January 28, 2021
    Applicant: West Affum Holdings Corp.
    Inventors: Joseph L. Sullivan, Pamela F. Breske, Phillip D. Foshee, JR., Laura M. Gustavson, Regina New, Krystyna Szul
  • Publication number: 20200114156
    Abstract: A wearable cardioverter defibrillator (WCD) comprises a support structure to be worn by a patient, an energy storage module to store an electrical charge, a discharge circuit coupled to the energy storage module, a measurement circuit, a user interface that includes a speaker, and a processor.
    Type: Application
    Filed: December 10, 2019
    Publication date: April 16, 2020
    Applicant: West Affum Holdings Corp.
    Inventors: Phillip D. Foshee, JR., David P. Finch, Laura M. Gustavson, Nikolai Korsun, Joseph L. Sullivan, Gregory T. Kavounas
  • Publication number: 20200027568
    Abstract: A physician house call portal comprises a processor and a memory coupled to the processor to store a patient station application, a communication system to communicate with a physician station via a network, an input/output (I/O) system coupled with an input device and an output device to allow a patient to communicate with a medical practitioner using the physician station, and a medical sensor to obtain a patient physiological parameter using the patient station application. Instructions in the memory configure the processor to allow the medical practitioner to perform an examination of the patient using the medical sensor.
    Type: Application
    Filed: July 17, 2019
    Publication date: January 23, 2020
    Inventors: Phillip D. Foshee, Jr., Zoie R. Engman, Daniel J. Finney
  • Patent number: 10500403
    Abstract: A wearable cardioverter defibrillator (“WCD”) system may output a loud sound after detecting and validating a shockable cardiac arrhythmia. In such embodiments, however, the WCD system might not sound a loud alarm before validating the arrhythmia thoroughly, i.e. for a longer time, thus giving the arrhythmia a further chance to self-terminate. The WCD system may thus detect more robustly the cardiac arrhythmias that do not self-terminate quickly. Such arrhythmias that self-terminate quickly may occur from likely harmless events occurring multiple times in the daily life of the patient, such as the patient becoming “winded” from climbing stairs. In embodiments the WCD system may notify the patient only discreetly, or even not at all. The lack of sounding such a loud alarm responsive to such events reduces the overall number of times in which the patient experiences unwanted attention by others, embarrassment, loss of privacy and dignity, and so on.
    Type: Grant
    Filed: July 12, 2017
    Date of Patent: December 10, 2019
    Assignee: WEST AFFUM HOLDINGS CORP.
    Inventors: Phillip D. Foshee, Jr., David P. Finch, Laura M. Gustavson, Nikolai Korsun, Joseph L. Sullivan
  • Publication number: 20190366110
    Abstract: In one embodiment, a carrying case for a wearable cardioverter defibrillator (WCD) is described. The carrying case includes a container with a front wall, a rear wall, and a gusset coupling the front wall and the rear wall. The carrying case also includes each of the front wall and rear wall including multiple fabric layers. The carrying case also includes two connection points inset from an edge of the rear wall. The carrying case also includes an adjustable strap removably coupled to the connection points, the adjustable strap configured to be worn in various configurations on a body of a patient.
    Type: Application
    Filed: May 29, 2019
    Publication date: December 5, 2019
    Inventors: Garett M. Kotlarchik, Kiah Lesher, Phillip D. Foshee, JR., Daniel J. Finney, David P. Finch
  • Patent number: 10426966
    Abstract: In some embodiments, a wearable cardioverter defibrillator (“WCD”) system may output a closing human-perceptible indication, after detecting a shockable cardiac arrhythmia, and after further determining that it will not shock. This may succeed in informing the patient that the WCD system will not deliver a shock responsive to the cardiac arrhythmia, which may have just self-terminated. The information may give comfort to the patient who may be conscious, and may recognize that his or her ventricular tachycardia has self-terminated. Moreover, the patient will know that he or she will not be unnecessarily shocked while conscious, and will not even need to press a cancel switch.
    Type: Grant
    Filed: August 9, 2017
    Date of Patent: October 1, 2019
    Assignee: WEST AFFUM HOLDINGS CORP.
    Inventors: Phillip D. Foshee, Jr., David P. Finch, Laura M. Gustavson, Nikolai Korsun, Joseph L. Sullivan, Gregory T. Kavounas
  • Publication number: 20190159696
    Abstract: A Wearable Cardioverter Defibrillator (WCD) system comprises an electrode assembly with a permeable ECG electrode and a moisture barrier. In some embodiments, the moisture barrier is configured to reduce drying out of the permeable ECG electrode to improve performance of the WCD system. In a further enhancement, some embodiments of the electrode assembly also include a pillow structure positioned on a non-skin-contacting surface of the electrode assembly to comfortably reduce movement artifact or noise in the received ECG signal.
    Type: Application
    Filed: November 20, 2018
    Publication date: May 30, 2019
    Inventors: Dallas E. Meeker, Kiah Lesher, Douglas K. Medema, Robert R. Buchanan, Zoie R. Engman, Phillip D. Foshee, JR., David P. Finch
  • Publication number: 20190143131
    Abstract: In embodiments, a Wearable Cardioverter Defibrillator (WCD) system includes a support structure for the patient to wear, and components that the support structure maintains on the patient's body. The components include a defibrillator, associated electrodes, and so on. The defibrillator can operate in a WCD mode while the patient wears the support structure. The defibrillator can further operate in a different, AED mode, during which time the patient need not wear a portion of the support structure, or even the entire support structure. Sometimes the AED mode is a type of a fully automatic AED mode. Other times the AED mode is a type of a semi-automated AED mode, where an attendant is present to administer the shock; at such times, the patient may not even need to have electrodes attached. This way the patient is more comfortable for a longer time.
    Type: Application
    Filed: September 28, 2018
    Publication date: May 16, 2019
    Inventors: Brian D. Webster, Zoie Engman, Phillip D. Foshee, JR., David P. Finch, Joseph L. Sullivan, Gregory T. Kavounas
  • Publication number: 20190143133
    Abstract: A wearable cardioverter defibrillator (WCD) having a processor configured to receive a signal indicating a position and/or movement of the ambulatory patient while the ambulatory patient is wearing the support structure receive the ECG signal, determine from an ECG signal whether a shock criterion is met, determine a confirmation time period and/or a response time period based on the position and/or movement of the ambulatory patient, determine from the ECG signal whether the shock criterion is met after the confirmation time period has elapsed, cause the user interface to generate the shock alert signal based on the shock criterion determined after the confirmation time period has elapsed, and control the discharge circuit to discharge the stored electrical charge when a predetermined time period has elapsed after the shock alert signal.
    Type: Application
    Filed: January 5, 2018
    Publication date: May 16, 2019
    Inventors: Phillip D. Foshee, JR., David P. Finch, Pamela Breske, Laura M. Gustavson, Joseph L. Sullivan, Jaeho Kim
  • Publication number: 20180185662
    Abstract: A wearable cardioverter defibrillator (WCD) having a processor configured to receive a signal indicating a position and/or movement of the ambulatory patient while the ambulatory patient is wearing the support structure receive the ECG signal, determine from an ECG signal whether a shock criterion is met, determine a confirmation time period and/or a response time period based on the position and/or movement of the ambulatory patient, determine from the ECG signal whether the shock criterion is met after the confirmation time period has elapsed, cause the user interface to generate the shock alert signal based on the shock criterion determined after the confirmation time period has elapsed, and control the discharge circuit to discharge the stored electrical charge when a predetermined time period has elapsed after the shock alert signal.
    Type: Application
    Filed: January 5, 2018
    Publication date: July 5, 2018
    Inventors: Phillip D. Foshee, JR., David P. Finch, Pamela Breske, Laura M. Gustavson, Joseph L. Sullivan, Jaeho Kim
  • Publication number: 20170368363
    Abstract: In some embodiments, a wearable cardioverter defibrillator (“WCD”) system may output a closing human-perceptible indication, after detecting a shockable cardiac arrhythmia, and after further determining that it will not shock. This may succeed in informing the patient that the WCD system will not deliver a shock responsive to the cardiac arrhythmia, which may have just self-terminated. The information may give comfort to the patient who may be conscious, and may recognize that his or her ventricular tachycardia has self-terminated. Moreover, the patient will know that he or she will not be unnecessarily shocked while conscious, and will not even need to press a cancel switch.
    Type: Application
    Filed: August 9, 2017
    Publication date: December 28, 2017
    Inventors: Phillip D. Foshee, JR., David P. Finch, Laura M. Gustavson, Nikolai Korsun, Joseph L. Sullivan, Gregory T. Kavounas
  • Publication number: 20170319862
    Abstract: A wearable cardioverter defibrillator (“WCD”) system may output a loud sound after detecting and validating a shockable cardiac arrhythmia. In such embodiments, however, the WCD system might not sound a loud alarm before validating the arrhythmia thoroughly, i.e. for a longer time, thus giving the arrhythmia a further chance to self-terminate. The WCD system may thus detect more robustly the cardiac arrhythmias that do not self-terminate quickly. Such arrhythmias that self-terminate quickly may occur from likely harmless events occurring multiple times in the daily life of the patient, such as the patient becoming “winded” from climbing stairs. In embodiments the WCD system may notify the patient only discreetly, or even not at all. The lack of sounding such a loud alarm responsive to such events reduces the overall number of times in which the patient experiences unwanted attention by others, embarrassment, loss of privacy and dignity, and so on.
    Type: Application
    Filed: July 12, 2017
    Publication date: November 9, 2017
    Inventors: Phillip D. Foshee, JR., David P. Finch, Laura M. Gustavson, Nikolai Korsun, Joseph L. Sullivan
  • Patent number: D825060
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: August 7, 2018
    Assignee: WEST AFFUM HOLDINGS CORP.
    Inventors: David P. Finch, Phillip D. Foshee, Jr., Laura M. Gustavson, Robert R. Buchanan, Kenneth Cowan, Daniel J. Finney, Jason W. Fouts, Karen E. McEwen